289 related articles for article (PubMed ID: 8501153)
61. Growth hormone and the kidney: the use of recombinant human growth hormone (rhGH) in growth-retarded children with chronic renal insufficiency.
Fine RN
J Am Soc Nephrol; 1991 Apr; 1(10):1136-45. PubMed ID: 1768809
[TBL] [Abstract][Full Text] [Related]
62. Function of the growth hormone-insulin-like growth factor I axis in the profoundly growth-retarded diabetic child: evidence for defective target organ responsiveness in the Mauriac syndrome.
Mauras N; Merimee T; Rogol AD
Metabolism; 1991 Oct; 40(10):1106-11. PubMed ID: 1719338
[TBL] [Abstract][Full Text] [Related]
63. Metabolic status of children with growth hormone insensitivity syndrome and responses to treatment with IGF-I.
Brain CE; Hubbard M; Preece MA; Savage MO; Aynsley-Green A
Horm Res; 1998; 50(2):61-70. PubMed ID: 9701698
[TBL] [Abstract][Full Text] [Related]
64. Familial short stature with very high levels of growth hormone binding protein.
Rieu M; Le Bouc Y; Villares SM; Postel-Vinay MC
J Clin Endocrinol Metab; 1993 Apr; 76(4):857-60. PubMed ID: 8473396
[TBL] [Abstract][Full Text] [Related]
65. Effect of a short-term treatment with recombinant growth hormone (GH) on adrenal responsiveness to corticotrophin stimulation in children affected by isolated GH deficiency.
Merola B; Rossi E; Colao A; Cataldi M; Longobardi S; Schettini G; Lombardi G
J Clin Endocrinol Metab; 1992 May; 74(5):1210-4. PubMed ID: 1314848
[TBL] [Abstract][Full Text] [Related]
66. [Measurement IGF-I in human blood by immunoenzymometric assay].
Segawa M
Nihon Naibunpi Gakkai Zasshi; 1992 Jul; 68(7):688-700. PubMed ID: 1516723
[TBL] [Abstract][Full Text] [Related]
67. Bone density and body composition in children with growth hormone insensitivity syndrome receiving recombinant IGF-I.
Shaw NJ; Fraser NC; Rose S; Crabtree NJ; Boivin CM
Clin Endocrinol (Oxf); 2003 Oct; 59(4):487-91. PubMed ID: 14510912
[TBL] [Abstract][Full Text] [Related]
68. The insulin-like growth factor I generation test in the investigation of short stature.
Cotterill AM; Camacho-Hübner C; Woods K; Martinelli C; Duquesnoy P; Savage MO
Acta Paediatr Suppl; 1994 Apr; 399():128-30. PubMed ID: 7949597
[TBL] [Abstract][Full Text] [Related]
69. Resistance to the growth-promoting and metabolic effects of growth hormone in children with chronic liver disease.
Bucuvalas JC; Cutfield W; Horn J; Sperling MA; Heubi JE; Campaigne B; Chernausek SD
J Pediatr; 1990 Sep; 117(3):397-402. PubMed ID: 2391594
[TBL] [Abstract][Full Text] [Related]
70. The use of recombinant human growth hormone in short children with chronic renal failure.
Mehls O; Tönshoff B; Haffner D; Wühl E; Schaefer F
J Pediatr Endocrinol; 1994; 7(2):107-13. PubMed ID: 8061755
[TBL] [Abstract][Full Text] [Related]
71. Growth hormone-binding protein levels: studies of children with short stature.
Mauras N; Carlsson LM; Murphy S; Merimee TJ
Metabolism; 1994 Mar; 43(3):357-9. PubMed ID: 8139484
[TBL] [Abstract][Full Text] [Related]
72. Short stature, growth hormone, insulin-like growth factors, and serum proteins in the Mountain Ok people of Papua New Guinea.
Schwartz J; Brumbaugh RC; Chiu M
J Clin Endocrinol Metab; 1987 Nov; 65(5):901-5. PubMed ID: 3667885
[TBL] [Abstract][Full Text] [Related]
73. Disturbance of growth hormone--insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment.
Tönshoff B; Schaefer F; Mehls O
Pediatr Nephrol; 1990 Nov; 4(6):654-62. PubMed ID: 2088470
[TBL] [Abstract][Full Text] [Related]
74. Resistance of nitrogen metabolism to growth hormone treatment in the early phase after injury of patients with multiple injuries.
Roth E; Valentini L; Semsroth M; Hölzenbein T; Winkler S; Blum WF; Ranke MB; Schemper M; Hammerle A; Karner J
J Trauma; 1995 Jan; 38(1):136-41. PubMed ID: 7538170
[TBL] [Abstract][Full Text] [Related]
75. Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure.
Clark RG
Pediatr Nephrol; 2005 Mar; 20(3):290-4. PubMed ID: 15682316
[TBL] [Abstract][Full Text] [Related]
76. Effects of growth hormone administration on neurotensin release in children with growth delay.
Schimpff RM; Bozzola M; Lhiaubet AM; Spadaro B; Tettoni K; Rostène W
Horm Res; 1994; 42(3):95-9. PubMed ID: 7995619
[TBL] [Abstract][Full Text] [Related]
77. Renal effects of growth hormone. I. Renal function and kidney growth.
Ogle GD; Rosenberg AR; Kainer G
Pediatr Nephrol; 1992 Jul; 6(4):394-8. PubMed ID: 1498008
[TBL] [Abstract][Full Text] [Related]
78. Endocrine characteristics of a miniature condition in Brahman cattle: circulating concentrations of some growth-related hormones.
Hammond AC; Elsasser TH; Olson TA
Proc Soc Exp Biol Med; 1991 Sep; 197(4):450-7. PubMed ID: 1871156
[TBL] [Abstract][Full Text] [Related]
79. Growth retardation in Down syndrome in relation to insulin-like growth factors and growth hormone.
Annerén G; Gustavson KH; Sara VR; Tuvemo T
Am J Med Genet Suppl; 1990; 7():59-62. PubMed ID: 1963538
[TBL] [Abstract][Full Text] [Related]
80. Determination of insulin-like growth factor I in children: normal values and clinical use.
Juul A
Horm Res; 2001; 55 Suppl 2():94-9. PubMed ID: 11684885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
